The majority opinion (per Justice Douglas) held that the properties of inhibition or of noninhibition in the bacteria were "the work of nature.,"
The court of appeals thought that packaging the non-inhibitory strains together went beyond the discovery of a phenomenon of nature and conferred patentability, because a "new and different composition of noninhibitive strains .. contributed utility and economy to the manufacture and distribution of commercial inoculants."